Inhalation & Drug Delivery
Dry-Powder Nasal Spray Testing: Phase 1 Characterization
The study established an early performance baseline for comparing the two variants and provided data for a regulatory-facing Phase 1 characterization package. It did not assess clinical efficacy or support claims of approval.
Selected findingRecovered material was predominantly classified in the nasal or upper-airway region for both variants.